| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.29 | 0.03 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.097 | 0.03 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.34 | 0.03 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |